Form 4 for RPRX Royalty Pharma plc
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-14 · accession 0001802768-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-02-18 | 2025-02-14 | RPRX | Hite Christopher | EVP, Vice COB | C - Cnv Deriv | $0.00 | +300.0K | 600.0K | +100% | $0 |
| DI | 2025-02-18 | 2025-02-14 | RPRX | Hite Christopher | EVP, Vice COB | C - Cnv Deriv | $0.00 | -30.0K | 86.6K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2025-02-14 | C | A | 300,000 | $0.00 | 600,000 | I By SCH Investment Partners LLC | — | — | |
| 2 | Derivative | LP interests in RPI US Partners 2019, LP | 2025-02-14 | C | D | 30,000 | $0.00 | 86,641 | I By SCH Investment Partners LLC | $0.00 · — to — | 300,000 Class A Ordinary Shares | (F2) Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Royalty Pharma Holdings, Ltd. ("Holdings") at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. |